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Glucagon and epinephrine promote the inactivation of basal glycogen synthase in hepatocytes i olated from 
fed rats. However, this effect is only observable when the activation state of glycogen synthase is measured 
using the low glucose-6-P/high glucose-6-P activity ratio assay. This inactivation is the consequence of an 
increase in the kinetic parameters (S, 5 for UDP-glucose and MO 5 for glucose-6-P) of the enzyme. Therefore, 
this work demonstrates these hormones are also able to control glycogen synthase from fed animals. 
(Rat hepatocyte) Glucagon 
1. INTRODUCTION 
Liver glycogen synthase (EC 2.4.1.1 l), the rate- 
limiting enzyme in glycogen biosynthesis, is subject 
to hormonal control [1,2]. Glycogenolytic hor- 
mones, such as glucagon and epinephrine, inac- 
tivate glycogen synthase as they are able to 
decrease the standard - glucosed-P/ + glucose- 
6-P activity ratio of this enzyme [3,4]. To date, 
these inactivating effects have been observed in 
hepatocytes from fasted rats but, surprisingly, no 
effects of these hormones on basal glycogen syn- 
thase activity have been detected when the hepato- 
cytes are isolated from fed rats. Therefore, it has 
been concluded that neither epinephrine nor glu- 
cagon is able to inactivate glycogen synthase in 
liver cells from fed rats [3,5] unless the enzyme is 
previously activated by incubation of the hepato- 
cytes with a high concentration of glucose, such as 
30 mM [4]. 
This lack of effect has been attributed to the 
known inhibition of glycogen synthase phospha- 
tase by the high levels of glycogen present in the 
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liver from fed rats [6]. According to this theory the 
inhibition of glycogen synthase phosphatase would 
keep glycogen synthase in a highly phosphorylated 
state not able to be further increased by hormones 
[31. 
Here, we have re-investigated the action of 
glucagon and epinephrine on glycogen synthase 
from liver cells isolated from fed animals, applying 
the low glucose-6P/high glucose-6-P activity ratio 
to measure the activation state of this enzyme [7]. 
We show that these hormones inactivate glycogen 
synthase by changing its kinetic parameters. 
2. MATERIALS AND METHODS 
Suspensions of isolated parenchymal iver cells 
were prepared from fed male Wistar rats 
(200-250 g) as in [8]. Cells were finally resuspend- 
ed in Krebs-bicarbonate buffer pre-gassed with 
OZ/COz (pH 7.4) free of glucose or any other 
substrate. 
Aliquots (5 ml, 8 x lo6 cells/ml) were poured in- 
to stoppered vials and incubated at 37°C with 
shaking (100 strokes/min) with saline (control) or 
hormones. At the end of the incubations the con- 
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tents of each vial was centrifuged (3000 x g, 20 s) 
and the cell pellet immediately homogenized with 
150 ~1 ice-cold medium containing 300 mM KF 
and 30 mM EDTA (pH 7.0) using a motor-driven 
Potter-Elvehjem homogenizer. The cell homogen- 
ates were centrifuged at 10000 x g for 15 min and 
the supernatants filtered through Ultrogel AcA 202 
columns (1 x 15 cm) equilibrated with extraction 
buffer, all at 4°C. The protein eluate was divided 
into two (500 PUI t- 300 ~1) aliquots. The first was 
directly assayed for glycagen synthase activity 
using: (i) the - glucosed-P/ + glucose-6-P standard 
assay (UDP-glucose concentration in reaction mix- 
ture, 4.4 mM) [9]; (ii) the low glucose-6-P/high 
glucose-6-P activity assay (UDP-glucose concen- 
tration in reaction mixture, 0.2 mM) [7] at 250 PM 
and 10 mM glucose-6-P, respectively. 
0 123456 10 12 
MIN 
Likewise, in this aliquot A40.5: was estimated 
from Hill plots of log( V,/V,,,, - V,) vs 
log[glucosed-P] as in [lo]. The second 300 ~1 ali- 
quot was incubated for 30 min at 4°C with 2 U 
glucose-6-P dehydrogenase and 0.13 pmol NADP+ 
to eliminate any trace of glucose-6-P left after col- 
umn processing. So.5 was then estimated from Hill 
plots of log( v/ vslstd - v) vs log[UDPG] as in [lo]. 
Fig.1. Effect of incubating hepatocytes from fed rats 
with 10-s M glucagon (A, A), 10m6 M epinephrine 
( q , w) or saline (o,o) on the - glucose-&P/ + glucose- 
6-P (A , q ,o) and low glucose-6-P/high glucose-6-P 
(A , n ,o) activity ratios of glycogen synthase. Results 
are means + SD of 13 experiments performed on 
different days. 
Protein was determined by the biuret method Sigma or Merck. Collagenase came from Wor- 
[l l] as in [12]. All the chemical reagents utilized thington, and bovine serum albumin (fraction V), 
were of analytical grade and obtained either from glucagon and epinephrine from Sigma. 
0.45 
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Fig.2. Concentration dependence of the effect of glucagon (A) and epinephrine (w) on the low glucose-6-P/high 
glucose-6-P (0.25 mM/lO mM) activity ratio of glycogen synthase in hepatocytes from fed rats. Cells were incubated 
for 3 min (glucagon) or 5 min (epinephrine) at the indicated concentrations. Results are mean f SD of 2 3 experiments 
performed on different days. 
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3. RESULTS 
3.1. Effects of glucagon and epinephrine on 
glycogen synthase activity of hepatocytes 
isolated from fed rats 
When hepatocytes from fed rats were incubated 
with lo-* M glucagon or lop6 M epinephrine, in 
the absence of glucose, no effect of these hor- 
mones on glycogen synthase activity could be 
observed if the activation state of the enzyme was 
measured applying the standard assay based on the 
- glucose-6-P/ + glucose-6-P activity ratio. How- 
ever, a clear-cut inactivation of glycogen synthase 
was demonstrated when the low glucose-6P/high 
glucose-6-P activity ratio assay was used. 
The inactivation of glycogen synthase by 
glucagon or epinephrine was time-dependent. 
Maximal effects were observed at 3 min (glucagon) 
and 5 min (epinephrine) of incubation. At 
lo-12 min the activity of the enzyme had returned 
to the original value (fig.1). , 
This effect was also concentration-dependent. 
The half-maximal effect was obtained at 5 x 
lo-” M glucagon and 2 x lo-’ M epinephrine 
(fig.2). 
3.2. Effects of glucagon and epinephrine on the 
kinetic properties of glycogen synthase 
Upon cell incubation with either glucagon 
(lo-’ M, 3 min), epinephrine (lo-’ M, 5 min) or 
saline (control), kinetic constants of glycogen syn- 
thase, So.5 for the substrate UDP-glucose and Mo.5 
for the allosteric activator glucosed-P, were deter- 
mined on hepatocyte extracts. The action of these 
Table 1 
Influence of glucagon and epinephrine on So.5 for UDP- 
glucose and A40.s for glucose-6-P of glycogen synthase in 
hepatocytes from fed rats 
so.5 MO.5 
for UDPG (mM) for G6P (cLM) 
Control 39 + 2 678 + 30 
Glucagon 61 f 2 1010 f 24 
Epinephrine 66 f 3 1155 + 38 
Cells were incubated with lo-’ M glucagon for 3 min or 
lo-’ M epinephrine for 5 min. Results are means + SD 
of r5 experiments performed on different days 
hormones resulted in a noticeable increase in both 
So.5 and it& over the control values (table 1). 
4. DISCUSSION 
Our results prove that glucagon and epinephrine 
are indeed able to inactivate hepatocyte glycogen 
synthase from fed rats. This effect had previously 
been overlooked because of a methodological 
problem. The activation state of glycogen synthase 
has been commonly determined by the ratio of the 
activities measured in the absence and presence of 
glucose-6-P using a concentration of substrate of 
4.4 mM UDP-glucose. As we have shown in [7], 
what this ratio measures are the changes in the So.5 
value for UDP-glucose. Hence, those effecters 
producing a decrease in So.5 for the substrate cause 
an increase in the activity ratio which results in ac- 
tivation of the enzyme. On the other hand, when 
So.5 is increased, the activity ratio decreases and 
then an inactivation is observed. As indicated in [7] 
the standard - glucosed-P/ + glucose-6-P activity 
ratio is sensitive to changes in So.5 when these take 
place at values close to that of the concentration of 
UDP-glucose used in the assay (4.4 mM). For ex- 
ample, an increase in So.5 for UDP-glucose from 4 
to 8 mM changes the activity ratio from 0.52 to 
0.35. However, a change in this kinetic constant 
from 40 to 80 mM only decreases the 
- glucosed-P/ + glucose-6-P ratio from 0.09 to 
0.05. Such a decrease would be overlooked in most 
cases. 
As shown in table 1, the So.5 value of glycogen 
synthase in hepatocytes from fed rats is approx. 
40 mM and increases as a result of glucagon or 
epinephrine action to values between 60 and 
70 mM. Changes in this range are almost undetect- 
able by the standard - glucose-6-P/ + glucose-6-P 
activity ratio and most likely for that reason effects 
of these hormones on hepatic glycogen synthase 
from fed rats had not been observed. 
An alternative method of measuring changes in 
glycogen synthase activity is by using the low 
glucosed-P/high glucose-6-P activity ratio assay 
described in [7]. This ratio is sensitive to changes 
in MO.S for glucose-6-P and has proven to be much 
more useful than the standard in showing the ef- 
fects of hormones [7,13,14] and other agents 
[ 15-181 on glycogen synthase. It is by using this 
method that we have been able to show, for the 
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first time, the effect of glucagon and epinephrine 
on basal hepatic glycogen synthase from fed rats. 
Then, we conclude that, although glycogen syn- 
thase is already present in a very low activation 
state in these animals, it can still be further inac- 
tivated by glycogenolytic hormones. 
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